Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “RA PHARMACEUTICALS, INC.”

115 pharma patents match "RA PHARMACEUTICALS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 115
Index total 30,257
Page 1 / 5

Quick answer

This filtered view shows 115 pharmaceutical patents matching "RA PHARMACEUTICALS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

115 results for “RA PHARMACEUTICALS, INC.” · 30,257 patents in full index Clear search

  1. US 12370142

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Jul 29, 2025 · Expires Jul 24, 2045

    granted

  2. US 12318483

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Jun 3, 2025 · Expires May 29, 2045

    granted

  3. US 12296047

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted May 13, 2025 · Expires May 8, 2045

    granted

  4. US 12285419

    Bupivacaine multivesicular liposome formulations and uses thereof

    Pacira Pharmaceuticals, Inc. · Granted Apr 29, 2025 · Expires Apr 24, 2045

    granted

  5. US 12285435

    Multivesicular liposome formulations of dexamethasone

    Pacira Pharmaceuticals, Inc. · Granted Apr 29, 2025 · Expires Apr 24, 2045

    granted

  6. US 12280149

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Apr 22, 2025 · Expires Apr 17, 2045

    granted

  7. US 12251468

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Mar 18, 2025 · Expires Mar 13, 2045

    granted

  8. US 12251472

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Mar 18, 2025 · Expires Mar 13, 2045

    granted

  9. US 12246092

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted

  10. US 12239684

    Modulators of complement activity

    RA PHARMACEUTICALS, INC. · Granted Mar 4, 2025 · Expires Feb 27, 2045

    granted

  11. US 12226610

    Treatment of pain associated with total knee arthroplasty with sustained-release liposomal anesthetic compositions

    Pacira Pharmaceuticals, Inc. · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted

  12. US 12178909

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Dec 31, 2024 · Expires Dec 26, 2044

    granted

  13. US 12156940

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Dec 3, 2024 · Expires Nov 28, 2044

    granted

  14. US 12151024

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Nov 26, 2024 · Expires Nov 21, 2044

    granted

  15. US 12144890

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Nov 19, 2024 · Expires Nov 14, 2044

    granted

  16. US 12012468

    Cyclic polypeptides for PCSK9 inhibition

    RA PHARMACEUTICALS, INC. · Granted Jun 18, 2024 · Expires Jun 13, 2044

    granted

  17. US 11965040

    Modulation of complement activity

    RA PHARMACEUTICALS, INC. · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted

  18. US 11932705

    Cyclic polypeptides for PCSK9 inhibition

    RA PHARMACEUTICALS, INC. · Granted Mar 19, 2024 · Expires Mar 14, 2044

    granted

  19. US 11931459

    Treatment of pain in pediatric patients by administration of sustained-release liposomal anesthetic compositions

    Pacira Pharmaceuticals, Inc. · Granted Mar 19, 2024 · Expires Mar 14, 2044

    granted

  20. US 11925706

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Mar 12, 2024 · Expires Mar 7, 2044

    granted

  21. US 11918688

    Treatment of hip pain with sustained-release liposomal anesthetic compositions

    Pacira Pharmaceuticals, Inc. · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted

  22. US 11918565

    Treatment of post-operative pain via sciatic nerve block with sustained-release liposomal anesthetic compositions

    Pacira Pharmaceuticals, Inc. · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted

  23. US 11819574

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted

  24. US 11819573

    Treatment of hip pain with sustained-release liposomal anesthetic compositions

    Pacira Pharmaceuticals, Inc. · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.